Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Pasithea Therapeutics Corp ( (KTTA) ).
On June 20, 2025, Pasithea Therapeutics Corp. increased the maximum aggregate offering price of its common stock under the At The Market Offering Agreement with H.C. Wainwright & Co., LLC, from $2,076,000 to $4,227,000. This adjustment allows the company to register an additional $2,151,000 worth of shares, potentially enhancing its market presence and financial flexibility.
More about Pasithea Therapeutics Corp
Average Trading Volume: 6,267,079
Technical Sentiment Signal: Sell
Current Market Cap: $5.77M
For detailed information about KTTA stock, go to TipRanks’ Stock Analysis page.

